Compare BJ & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BJ | BAX |
|---|---|---|
| Founded | 1984 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 10.2B |
| IPO Year | 2018 | N/A |
| Metric | BJ | BAX |
|---|---|---|
| Price | $102.78 | $19.79 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 10 |
| Target Price | ★ $108.80 | $25.00 |
| AVG Volume (30 Days) | 2.0M | ★ 9.7M |
| Earning Date | 03-05-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.21% |
| EPS Growth | ★ 4.02 | N/A |
| EPS | ★ 4.34 | N/A |
| Revenue | ★ $21,160,412,000.00 | $11,244,000,000.00 |
| Revenue This Year | $7.66 | $1.50 |
| Revenue Next Year | $6.47 | $2.99 |
| P/E Ratio | $23.18 | ★ N/A |
| Revenue Growth | 2.82 | ★ 5.72 |
| 52 Week Low | $86.68 | $17.40 |
| 52 Week High | $121.10 | $37.74 |
| Indicator | BJ | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 63.14 | 41.16 |
| Support Level | $96.85 | $18.58 |
| Resistance Level | $102.40 | $22.41 |
| Average True Range (ATR) | 2.99 | 0.69 |
| MACD | 0.53 | -0.13 |
| Stochastic Oscillator | 91.40 | 12.65 |
BJ's Wholesale serves as one of the few warehouse club chains in the United States. Its 250 warehouses are primarily located along the East Coast, most prominently in the New England area. Similar to its warehouse club peers, BJ's charges annual membership fees and keeps costs down by operating a "no-frills" store environment. The company limits the use of distribution centers where possible and stores inventory on pallets directly on the sales floor, often in bulk quantities. The company also offers a limited assortment of 7,000 stock-keeping units at its warehouses to achieve greater procurement scale on select items. About 80% of BJ's net sales come from grocery items and general merchandise, with the remaining 20% stemming from gasoline and other ancillary services.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.